Ingredient · Evidence grade C

Pycnogenol (pine bark) for menopause: evidence, studies and safety

Last updated · 2 studies summarized

C Short answer: Pycnogenol, a French maritime pine bark extract, has been studied in three controlled trials for occasional hot flashes and sleep problems in perimenopause*.

Key facts

Evidence gradeC C
Use studiedclimacteric symptoms
Trials3 placebo/controlled RCTs (n=170, ~200, 38)
Participants~400
What reviews concludeCochrane 2020 (pine bark, chronic disorders) did not include menopause and found low-quality evidence overall.
The Menopause Society (2023)Not assessed.
Also known asFrench maritime pine bark, Pinus pinaster, Oligopin

Grades: A strong · B moderate · C limited · D none or negative. How we grade.

Every study we reviewed

Each summary gives who took part, the dose, how long, the result compared with placebo or control, and who paid for it.

  • Effect of low-dose French maritime pine bark extract on climacteric syndrome in 170 perimenopausal women: a randomized, double-blind, placebo-controlled trial.

    Kohama T, Negami M · J Reprod Med 2013 · Pycnogenol (pine bark)

    170 Japanese women took a low dose of French maritime pine bark extract (60 mg a day) or placebo for 12 weeks. Symptoms, especially hot flashes and sleep, improved more than placebo, though placebo also helped a lot.

    Who
    170 perimenopausal women (Japan)
    Dose
    Pycnogenol 30 mg twice daily
    Duration
    12 weeks
    Result
    Kupperman -56% vs -39% placebo (P<.05); hot flashes and sleep improved.
    Funding
    Not stated in abstract (Horphag Research, maker, typically supports Pycnogenol trials; not verified). Funding not stated

    PubMed

  • A randomised, double-blind, placebo-controlled trial on the effect of Pycnogenol on the climacteric syndrome in peri-menopausal women.

    Yang HM, Liao MF, Zhu SY et al. · Acta Obstet Gynecol Scand 2007 · Pycnogenol (pine bark)

    About 200 Taiwanese women took 200 mg pine bark extract or placebo for 6 months, and symptoms improved more with the extract.

    Who
    200 enrolled, 155 completed (Taiwan)
    Dose
    Pycnogenol 200 mg/day
    Duration
    6 months
    Result
    All climacteric symptoms improved vs placebo; antioxidant status improved.
    Funding
    Not stated in abstract. Funding not stated

    PubMed · Full text (DOI)

Safety

Well tolerated in trials.

Ranked products that contain it

Ranked products containing Pycnogenol (pine bark), by our score.
ProductAmount per dayScore$/day
Kindra MenoReliefPycnogenol French maritime pine bark extract: 100 mg48.1$1.30
Womaness Me.No.Pause.Pycnogenol pine bark extract: 60 mg40.6$1.57

FAQ

Does Pycnogenol (pine bark) help with menopause symptoms?

Pycnogenol, a French maritime pine bark extract, has been studied in three controlled trials for occasional hot flashes and sleep problems in perimenopause*. Our evidence grade is C. Cochrane 2020 (pine bark, chronic disorders) did not include menopause and found low-quality evidence overall.

Does The Menopause Society recommend Pycnogenol (pine bark)?

Not assessed. The 2023 nonhormone statement recommends no dietary supplement for hot flashes; talk to a clinician about hormone therapy and prescription options.

Is Pycnogenol (pine bark) safe?

Well tolerated in trials. Supplements are not FDA-approved before sale; ask a clinician or pharmacist, especially if you take medication.

Sources

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Solynes does not sell supplements; descriptions summarize published research and are not medical advice.